|
|
| Research article summary (published 20 Nov 2004): |
|
Free Full Text! See links below |
The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study.
Full Abstract
BACKGROUND: The Menopause Rating Scale is a health-related Quality of Life scale developed in the early 1990s and step-by-step validated since then. No methodologically detailed work on the utility of the scale to assess health-related changes after treatment was published before. METHOD: We analysed an open, uncontrolled post-marketing study with over 9000 women with pre- and post-treatment data of the MRS scale to critically evaluate the capacity of the scale to measure the health-related effects of hormone treatment independent from the severity of complaints at baseline. RESULTS: The improvement of complaints during treatment relative to the baseline score was 36% in average. Patients with little/no complaints before therapy improved by 11%, those with mild complaints at entry by 32%, with moderate by 44%, and with severe symptoms by 55% - compared with the baseline score. We showed that the distribution of complaints in women before therapy returned to norm values after 6 months of hormone treatment. We also provided weak evidence that the MRS results may well predict the assessment of the treating physician. Limitations of the study, however, may have lead to overestimating the utility of the MRS scale as outcome measure. CONCLUSION: The MRS scale showed some evidence for its ability to measure treatment effects on quality of life across the full range of severity of complaints in aging women. This however needs confirmation in other and better-designed clinical/outcome studies.
Author information
Author/s: Heinemann, Lothar A J (LA); DoMinh, Thai (T); Strelow, Frank (F); Gerbsch, Silvia (S); Schnitker, Jörg (J); Schneider, Hermann P G (HP);
Affiliation: Center for Epidemiology & Health Research Berlin, Invalidenstr, 115, 10115 Berlin, German. Heinemann(-atsign-)zeg-berlin.de
Journal and publication information
Publication Type: Journal Article; Multicenter Study; Validation Studies
Journal: Health and quality of life outcomes (Health Qual Life Outcomes), published in England. (Language: eng)
Reference: 2004-; vol 2 (issue ) : pp 67
Dates: Created 2004/12/03; Completed 2005/05/16; Revised 2008/11/20;
PMID: 15555079, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Quality of life and hormone use: new validation results of MRS scale.
29 May 2006 - Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.
27 Dec 2000 - [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study]
29 Jun 2005 - [Hormone replacement therapy and uterine leiomyomas]
30 Dec 2000 - [Hormonal therapy in perimenopause]
30 Dec 1994 - The role of antiandrogens in hormone replacement therapy.
29 Nov 2000 - [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric]
30 Oct 2000 - Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it.
14 Oct 2005 - The Menopause Rating Scale (MRS) scale: a methodological review.
31 Aug 2004 - Sensitivity as outcome measure of androgen replacement: the AMS scale.
28 Mar 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.